← Leaderboards
Nicholas Arpaia
Columbia Univ New York Morningside
$10,668,029
Attributed
$15,250,621
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,250,621 · 9
By mechanism
R01$10,884,982 · 5
U01$2,937,508 · 1
UG3$727,904 · 1
R21$434,300 · 1
K22$265,927 · 1
Top collaborators
- Tal Danino16 shared
- Kam W Leong3 shared
Most similar at Columbia Univ New York Morningside
Same institution · by research overlap
- Tal Danino$10,808,082
Others in their field
Other Emerging Leaders on “Production”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$108,384,076
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
ProductionT-LymphocyteImmuneCellsEngineeringResponseMediatingTumorMalignant NeoplasmsImmunotherapyTumor ImmunityKineticsEscherichia ColiEngineered ProbioticsSynthetic BiologyProbioticsImmune SystemImmunotherapeutic AgentCytokineSourceLungPreventGrowthIn Vivo
Grant awards (31)
Engineered probiotic bacteria for colorectal cancer immunoprevention and interception$727,904
UG3 · FY2025 · CA · contact PI
Modulating the localization and persistence of microbial neoantigen vaccine vectors to enhance therapeutic efficacy$638,120
R01 · FY2025 · CA · contact PI
Programmable encapsulation systems to improve delivery of therapeutic bacteria$619,930
R01 · FY2025 · EB
Treating colon cancer by regulating intestinal immunity through microbial metabolism$565,434
R01 · FY2025 · CA · contact PI
Programmable encapsulation systems to improve delivery of therapeutic bacteria$617,386
R01 · FY2024 · EB
Lung leukocytes promote alveolar epithelial regeneration after severe injury$607,984
R01 · FY2024 · HL · contact PI
Engineering immunotherapeutic probiotics to mitigate irAE$571,668
U01 · FY2024 · CA
Treating colon cancer by regulating intestinal immunity through microbial metabolism$537,163
R01 · FY2024 · CA · contact PI
Modulation of the tumor microenvironment with probiotic therapies$525,502
R01 · FY2024 · CA
Lung leukocytes promote alveolar epithelial regeneration after severe injury$620,391
R01 · FY2023 · HL · contact PI
Programmable encapsulation systems to improve delivery of therapeutic bacteria$613,945
R01 · FY2023 · EB
Engineering immunotherapeutic probiotics to mitigate irAE$599,683
U01 · FY2023 · CA
Treating colon cancer by regulating intestinal immunity through microbial metabolism$554,126
R01 · FY2023 · CA · contact PI
Modulation of the tumor microenvironment with probiotic therapies$551,862
R01 · FY2023 · CA
Modulation of the tumor microenvironment with probiotic therapies$86,602
R01 · FY2023 · CA
Lung leukocytes promote alveolar epithelial regeneration after severe injury$620,391
R01 · FY2022 · HL · contact PI
Engineering immunotherapeutic probiotics to mitigate irAE$584,146
U01 · FY2022 · CA
Modulation of the tumor microenvironment with probiotic therapies$561,341
R01 · FY2022 · CA
Treating colon cancer by regulating intestinal immunity through microbial metabolism$554,126
R01 · FY2022 · CA · contact PI
Modulation of the tumor microenvironment with probiotic therapies$85,800
R01 · FY2022 · CA
Lung leukocytes promote alveolar epithelial regeneration after severe injury$620,391
R01 · FY2021 · HL · contact PI
Engineering immunotherapeutic probiotics to mitigate irAE$595,682
U01 · FY2021 · CA
Modulation of the tumor microenvironment with probiotic therapies$582,197
R01 · FY2021 · CA
Treating colon cancer by regulating intestinal immunity through microbial metabolism$561,400
R01 · FY2021 · CA · contact PI
Role of T cell-derived amphiregulin in recovery from influenza virus infection$197,940
R21 · FY2021 · AI · contact PI
Lung leukocytes promote alveolar epithelial regeneration after severe injury$635,891
R01 · FY2020 · HL · contact PI
Engineering immunotherapeutic probiotics to mitigate irAE$586,329
U01 · FY2020 · CA
Role of T cell-derived amphiregulin in recovery from influenza virus infection$236,360
R21 · FY2020 · AI · contact PI
Lung leukocytes promote alveolar epithelial regeneration after severe injury$125,000
R01 · FY2020 · HL · contact PI
Mechanisms mediating tissue repair by leukocytes during influenza virus infection$104,527
K22 · FY2018 · AI · contact PI
Mechanisms mediating tissue repair by leukocytes during influenza virus infection$161,400
K22 · FY2017 · AI · contact PI